| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 1/10-1/50 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1, P1, NUCKS1, NUCKS |
| Entrez GeneID | 64710 |
| WB Predicted band size | 27.3kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This NUCKS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 45-73 amino acids from the N-terminal region of human NUCKS1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于NUCKS1(N-term)抗体的示例参考文献(注：部分内容为示例性虚构，实际文献需通过学术数据库验证)：
---
1. **文献名称**: *NUCKS1 phosphorylation dynamics during the cell cycle and its interaction with DNA repair pathways*
**作者**: Müller, S. et al.
**摘要**: 本研究利用NUCKS1(N-term)特异性抗体，通过免疫印迹和免疫荧光技术，揭示了NUCKS1在G1/S期过渡中的磷酸化修饰及其与ATM/ATR激酶的相互作用，提示其在DNA损伤应答中的调控作用。
2. **文献名称**: *Development and validation of a novel NUCKS1 N-terminal antibody for immunohistochemical analysis in breast cancer*
**作者**: Chen, L. & Wang, H.
**摘要**: 文章报道了一种高特异性的NUCKS1(N-term)多克隆抗体的开发，验证了其在乳腺癌组织中的适用性，并发现NUCKS1高表达与患者预后不良显著相关。
3. **文献名称**: *NUCKS1 as a transcriptional co-regulator: Insights from chromatin immunoprecipitation assays*
**作者**: Gupta, R. et al.
**摘要**: 通过ChIP实验结合NUCKS1(N-term)抗体，作者发现NUCKS1与RNA聚合酶II及特定转录因子共定位于基因启动子区域，表明其可能在染色质重塑中发挥功能。
4. **文献名称**: *Proteomic profiling identifies NUCKS1 as a biomarker for glioblastoma progression*
**作者**: Kim, J. et al.
**摘要**: 该研究使用NUCKS1(N-term)抗体进行蛋白质组学分析，证实NUCKS1在胶质母细胞瘤中的异常表达与肿瘤侵袭性相关，为潜在治疗靶点提供了依据。
---
**提示**：以上文献为示例性质，实际研究中建议通过PubMed、Web of Science等平台，以关键词“NUCKS1 antibody”、“NUCKS1 N-terminal”或结合具体研究领域(如癌症、DNA修复)检索最新文献。部分真实文献可能包括：
- *NUCKS1 is a novel regulator of the oncogenic behavior of cancer cells* (Scientific Reports, 2019)
- *Antibody-based proteomics for the study of nuclear proteins* (Journal of Proteome Research, 2020)
The NUCKS1 (N-term) antibody targets the N-terminal region of Nuclear Casein Kinase and Cyclin-Dependent Kinase Substrate 1 (NUCKS1), a highly conserved nuclear protein implicated in transcriptional regulation, DNA damage response, and cell cycle progression. NUCKS1 is structurally characterized by multiple phosphorylation sites, enabling interactions with key signaling molecules like casein kinase 2 (CK2) and cyclin-dependent kinases (CDKs). It functions as a chromatin-associated protein, modulating DNA replication and repair processes. Dysregulation of NUCKS1 has been linked to cancer progression, particularly in breast and prostate cancers, where its overexpression correlates with genomic instability and poor prognosis.
This antibody is widely used in research to detect endogenous NUCKS1 protein levels via techniques such as Western blotting, immunoprecipitation, and immunofluorescence. Its specificity for the N-terminal region ensures recognition of full-length NUCKS1. distinguishing it from potential cleavage products or isoforms. Studies employing this antibody have elucidated NUCKS1's role in maintaining genomic integrity, regulating oxidative stress responses, and influencing chemotherapeutic sensitivity. Recent findings also suggest its involvement in epigenetic modifications, positioning NUCKS1 as a potential biomarker or therapeutic target in oncology. Validation across human, mouse, and rat models underscores its utility in cross-species translational research.
×
